Online SARMs dosing guides often look convincing. They list exact milligrams, morning and evening doses, and neatly defined cycle lengths. But a detailed schedule is not proof that a compound is safe or that the suggested routine has been tested in humans.
The list discussed here also mixes several different drug classes. Cardarine, MK-677, and SR9009 are frequently grouped with SARMs in bodybuilding discussions, but they work through different biological pathways.
What are these compounds?
CompoundClassification and evidenceRAD-140, LGD-4033, MK-2866 and S4Compounds commonly classified as SARMs. Evidence differs between them, and none has an FDA approved bodybuilding dosing schedule.S23, LGD-3303 and ACP-105Experimental SARMs with published preclinical research. Animal findings do not establish safe bodybuilding doses for humans.YK-11A steroidal androgen receptor partial agonist studied experimentally. Laboratory findings do not establish a safe human cycle.RAD-150Marketed as a modified version of RAD-140. Marketing claims do not establish its human safety, duration of action, or dosing frequency.GW-501516 and GW-0742Experimental compounds associated with PPAR delta activation, rather than selective androgen receptor modulation.MK-677, also called ibutamorenA growth hormone secretagogue, rather than a SARM.SR9009 and SR9011Research compounds studied as REV-ERB agonists. They are not SARMs, and their effects cannot be reduced to a simple bodybuilding dosing formula.
Published research illustrates these distinctions. Studies describe ACP-105 as a SARM, YK-11 as an androgen receptor partial agonist, and SR9009 and SR9011 as experimental REV-ERB agonists. These classifications explain research targets, not permission to use the compounds.
A 12 week schedule is not a validated safety limit
There is no established universal 12 week bodybuilding protocol for the compounds in this list. Taking a substance in the morning, dividing it into several doses, or increasing the amount after two weeks does not demonstrate that the routine is effective or safe.
Even studies involving humans need careful interpretation. A controlled study of LGD-4033 in healthy men lasted only 21 days and reported suppression of testosterone and reductions in HDL cholesterol. It did not validate a longer bodybuilding cycle or the much higher amounts often advertised online.
RAD-140 has also been investigated in a phase 1 breast cancer trial. Research conducted in patients with cancer cannot establish a suitable recreational regimen for healthy lifters.
Different drug classes bring different concerns
Cardarine deserves particular caution. A WADA alert explained that its development was discontinued after serious toxicities emerged in preclinical studies. Those findings do not quantify an individual user’s risk, but they undermine claims that an online cycle is proven safe.
MK-677 has its own concerns. The FDA identifies ibutamoren as an unapproved ingredient and describes possible water retention, altered glucose metabolism and insulin sensitivity, and potential congestive heart failure risk in certain individuals.
For SARMs, the FDA warns against use, citing reports of liver injury, sexual dysfunction, infertility, and potentially increased risk of heart attack or stroke. “Research use only” labeling does not establish safety for human consumption.
Combining compounds adds uncertainty
Whether this list is intended as separate options or one large stack matters. Neither interpretation turns it into a medically validated guide. Combining experimental compounds introduces additional uncertainty about interactions, overlapping adverse effects, and which substance is responsible if problems develop.
Bloodwork can help identify some problems, but normal results cannot certify an experimental cycle as safe. Supplements and a planned PCT also do not validate the original regimen.
Anyone already using these products should disclose the exact compounds, amounts, and duration to a healthcare professional. Someone considering starting should understand that the precision of a dosing chart can exceed the precision of the evidence behind it.
Nobody has answered this yet.
If you have run it, what happened to you is the answer. What you took and for how long, what changed, and your bloodwork if you have it.
You do not need to be an expert. You need to have taken it.